Article
Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
Atherosclerosis - 1 Mar 2014
Besseling Joost, Kindt Iris, Hof Michel, Kastelein John J P, Hutten Barbara A, Hovingh G Kees
Abstract excerpt
BACKGROUND: Some recently emerged lipid-lowering therapies are currently restricted to patients with homozygous familial hypercholesterolemia (HoFH), and studies are underway to also assess these therapies in patients with 'severe heterozygous FH (HeFH)'. However, no uniform definition of 'severe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
